Prognostic value of baseline FDG PET/CT in HER2-positive metastatic breast cancer treated with first-line trastuzumab, pertuzumab, and docetaxel
Year: 2025
Type: article
Language: en
Topic: HER2/EGFR in Cancer Research
Authors and affiliations:
raw_author_name: Marcin Kubeczko
raw_affiliation_strings: Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 15 Wybrzeze Armii Krajowej Street, 44-102, Gliwice, Upper Silesia, Poland. marcin.kubeczko@gliwice.nio.gov.pl
Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 15 Wybrzeze Armii Krajowej Street, 44-102, Gliwice, Upper Silesia, Poland
raw_author_name: Andrea d’Amico
raw_affiliation_strings: Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102, Gliwice, Poland
raw_author_name: Olgierd Chrabanski
raw_affiliation_strings: Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102, Gliwice, Poland
raw_author_name: Daria Handkiewicz-Junak
raw_affiliation_strings: Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102, Gliwice, Poland
raw_author_name: Anna Polakiewicz-Gilowska
raw_affiliation_strings: Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 15 Wybrzeze Armii Krajowej Street, 44-102, Gliwice, Upper Silesia, Poland
raw_author_name: Katarzyna Swiderska
raw_affiliation_strings: Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 15 Wybrzeze Armii Krajowej Street, 44-102, Gliwice, Upper Silesia, Poland
raw_author_name: Marta Mianowska-Malec
raw_affiliation_strings: Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 15 Wybrzeze Armii Krajowej Street, 44-102, Gliwice, Upper Silesia, Poland
raw_author_name: Aleksandra Lesniak
raw_affiliation_strings: Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 15 Wybrzeze Armii Krajowej Street, 44-102, Gliwice, Upper Silesia, Poland
raw_author_name: Barbarba Lanoszka
raw_affiliation_strings: Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 15 Wybrzeze Armii Krajowej Street, 44-102, Gliwice, Upper Silesia, Poland
raw_author_name: Natalya Lisovska
raw_affiliation_strings: Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 15 Wybrzeze Armii Krajowej Street, 44-102, Gliwice, Upper Silesia, Poland
raw_author_name: Damian Borys
raw_affiliation_strings: Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102, Gliwice, Poland
raw_author_name: Bartlomiej Pycinski
raw_affiliation_strings: Faculty of Biomedical Engineering, Silesian University of Technology, Roosevelta 40, 41-800, Zabrze, Poland
raw_author_name: Ewa Chmielik
raw_affiliation_strings: Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102, Gliwice, Poland
raw_author_name: Slawomir Blamek
raw_affiliation_strings: Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102, Gliwice, Poland
raw_author_name: Aleix Prat
raw_affiliation_strings: Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain
Medicine Department, University of Barcelona, Barcelona, Spain
Reveal Genomics, Barcelona, Spain
Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
raw_author_name: Michal Jarzab
raw_affiliation_strings: Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 15 Wybrzeze Armii Krajowej Street, 44-102, Gliwice, Upper Silesia, Poland